PepGen Inc. Files 8-K: Regulation FD & Exhibits
Ticker: PEPG · Form: 8-K · Filed: Oct 1, 2025 · CIK: 1835597
| Field | Detail |
|---|---|
| Company | Pepgen Inc. (PEPG) |
| Form Type | 8-K |
| Filed Date | Oct 1, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, financial-reporting
TL;DR
PepGen filed an 8-K for Reg FD and exhibits. Standard stuff.
AI Summary
PepGen Inc. filed an 8-K on October 1, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, incorporated in Delaware with its principal executive offices in Boston, MA, operates in the Pharmaceutical Preparations sector. The filing does not contain specific financial figures or event details beyond its classification.
Why It Matters
This 8-K filing indicates that PepGen Inc. is making disclosures under Regulation FD and submitting financial exhibits, which is a standard regulatory requirement for public companies.
Risk Assessment
Risk Level: low — This filing is a routine regulatory disclosure and does not contain information that inherently increases or decreases risk.
Key Players & Entities
- PepGen Inc. (company) — Registrant
- October 01, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Boston, Massachusetts (location) — Principal Executive Offices
- 001-41374 (identifier) — Commission File Number
FAQ
What specific event triggered this 8-K filing under Regulation FD?
The filing does not specify the event that triggered the Regulation FD disclosure, only that it is being reported.
What financial statements and exhibits are included in this filing?
The filing indicates that Financial Statements and Exhibits are being submitted, but the specific details of these documents are not provided in the summary information.
What is PepGen Inc.'s primary business activity?
PepGen Inc. is classified under the Standard Industrial Classification code 2834, which corresponds to Pharmaceutical Preparations.
When was PepGen Inc. incorporated and where are its principal executive offices located?
PepGen Inc. was incorporated in Delaware and its principal executive offices are located at 321 Harrison Avenue, 8th Floor, Boston, Massachusetts, 02118.
What is the Commission File Number for PepGen Inc.?
The Commission File Number for PepGen Inc. is 001-41374.
Filing Stats: 514 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2025-10-01 16:05:30
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 per share PEPG Nasdaq Global Select
Filing Documents
- pepg-20251001.htm (8-K) — 43KB
- pepg-ex99_1.htm (EX-99.1) — 23KB
- pepg-ex99_1s1.jpg (GRAPHIC) — 172KB
- pepg-ex99_1s2.jpg (GRAPHIC) — 819KB
- pepg-ex99_1s3.jpg (GRAPHIC) — 438KB
- pepg-ex99_1s4.jpg (GRAPHIC) — 350KB
- pepg-ex99_1s5.jpg (GRAPHIC) — 413KB
- pepg-ex99_1s6.jpg (GRAPHIC) — 366KB
- pepg-ex99_1s7.jpg (GRAPHIC) — 198KB
- pepg-ex99_1s8.jpg (GRAPHIC) — 428KB
- pepg-ex99_1s9.jpg (GRAPHIC) — 483KB
- pepg-ex99_1s10.jpg (GRAPHIC) — 400KB
- pepg-ex99_1s11.jpg (GRAPHIC) — 405KB
- pepg-ex99_1s12.jpg (GRAPHIC) — 384KB
- pepg-ex99_1s13.jpg (GRAPHIC) — 364KB
- pepg-ex99_1s14.jpg (GRAPHIC) — 280KB
- pepg-ex99_1s15.jpg (GRAPHIC) — 297KB
- pepg-ex99_1s16.jpg (GRAPHIC) — 315KB
- pepg-ex99_1s17.jpg (GRAPHIC) — 268KB
- pepg-ex99_1s18.jpg (GRAPHIC) — 421KB
- pepg-ex99_1s19.jpg (GRAPHIC) — 385KB
- pepg-ex99_1s20.jpg (GRAPHIC) — 350KB
- pepg-ex99_1s21.jpg (GRAPHIC) — 184KB
- 0001193125-25-226746.txt ( ) — 10814KB
- pepg-20251001.xsd (EX-101.SCH) — 25KB
- pepg-20251001_htm.xml (XML) — 5KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On October 1, 2025, PepGen Inc. (the "Company") updated its Corporate Presentation, a copy of which is being furnished as Exhibit 99.1 and incorporated herein by reference. The information in this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. This Current Report on Form 8-K will not be deemed an admission as to the materiality of any information in this Item 7.01 (including Exhibit 99.1).
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Number Description 99.1 Corporate Presentation updated as of October 1, 2025 104 Cover Page Interactive Data File (embedded within Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PEPGEN INC. Date: October 1, 2025 By: /s/ Noel Donnelly Noel Donnelly, Chief Financial Officer